← Open Payments lookup

HOLLY KALISH: Open Payments

NPI 1306334909 · HOCKESSIN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$730 in 39 payments from 15 companies in 2025. Trend: 2023 $212 · 2024 $680 · 2025 $730

Food & beverage: $730
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$167
ABBVIE INC.8$145
Novo Nordisk Inc5$89
Lilly USA, LLC4$73
Axsome Therapeutics, Inc.2$36
Phathom Pharmaceuticals, Inc.3$33
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
Merck Sharp & Dohme LLC1$26
Takeda Pharmaceuticals U.S.A., Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: FARXIGA, VRAYLAR, MOUNJARO, BREZTRI, Wegovy, VOQUEZNA, JARDIANCE, GARDASIL 9.

Industry payments across DE — which companies pay providers there.